Dexcom Inc (DXCM) concluded trading on Thursday at a closing price of $133.34, with 2.65 million shares of worth about $353.92 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 46.62% during that period and on April 4, 2024 the price saw a loss of about -3.73%. Currently the company’s common shares owned by public are about 385.40M shares, out of which, 377.37M shares are available for trading.
However, the stock later moved at a day high price of 136.25, or with a loss of -3.73%. Stock saw a price change of -4.40% in past 5 days and over the past one month there was a price change of 9.49%. Year-to-date (YTD), DXCM shares are showing a performance of 7.45% which increased to 15.71% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $74.75 but also hit the highest price of $142.00 during that period. The average intraday trading volume for Dexcom Inc shares is 3.10 million. The stock is currently trading -1.29% below its 20-day simple moving average (SMA20), while that difference is up 5.55% for SMA50 and it goes to 16.50% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Dexcom Inc (NASDAQ: DXCM) currently have 385.40M outstanding shares and institutions hold larger chunk of about 98.97% of that.
The stock has a current market capitalization of $51.40B and its 3Y-monthly beta is at 1.21. PE ratio of stock for trailing 12 months is 101.73, while it has posted earnings per share of $1.31 in the same period. Its PEG reads 3.05 and has Quick Ratio of 2.48 while making debt-to-equity ratio of 1.25. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for DXCM, volatility over the week remained 2.59% while standing at 3.32% over the month.
Stock’s fiscal year EPS is expected to rise by 15.38% while it is estimated to increase by 27.05% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by RBC Capital Mkts on March 12, 2024 offering an Outperform rating for the stock and assigned a target price of $165 to it. Coverage by Morgan Stanley stated Dexcom Inc (DXCM) stock as an Equal-weight in their note to investors on May 30, 2023, suggesting a price target of $131 for the stock. On April 17, 2023, Raymond James Upgrade their recommendations, while on March 29, 2023, UBS Initiated their ratings for the stock with a price target of $142. Stock get an Outperform rating from Wolfe Research on January 26, 2023.
